Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer
- PMID: 29495461
- PMCID: PMC5872176
- DOI: 10.3390/medsci6010019
Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer
Abstract
To assess the possibility of using the antimalarial drug artemisinin and its synthetic derivatives as antineoplastic drugs. A Pubmed and Google Scholar (1983-2018) search was performed using the terms artemisinin, cancer, artesunate and Artemisia annua. Case reports and original research articles, review articles, and clinical trials in both humans and animals were evaluated. Both in vitro and in vivo clinical trials and case reports have shown promising activity of the artemisinin drug derivatives in treating certain types of cancer. However, the reported articles are few, and therefore not statistically significant. The minimal toxicity shown in clinical trials and case reports, along with the selective cytotoxic activity of the compounds, make them possible cancer therapies due to the emerging evidence of the drug's effectiveness.
Keywords: artemisinin; cancer; malaria.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin.Phytomedicine. 2011 Aug 15;18(11):959-69. doi: 10.1016/j.phymed.2011.06.008. Epub 2011 Aug 9. Phytomedicine. 2011. PMID: 21831619
-
The complexity of medicinal plants: the traditional Artemisia annua formulation, current status and future perspectives.J Ethnopharmacol. 2013 Oct 28;150(1):1-13. doi: 10.1016/j.jep.2013.08.021. Epub 2013 Aug 20. J Ethnopharmacol. 2013. PMID: 23973523 Review.
-
Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment.Curr Pharm Des. 2019;25(31):3323-3338. doi: 10.2174/1381612825666190902155957. Curr Pharm Des. 2019. PMID: 31475891 Review.
-
Use of artesunate in non-malarial indications.Med Mal Infect. 2018 Jun;48(4):238-249. doi: 10.1016/j.medmal.2018.01.004. Epub 2018 Feb 13. Med Mal Infect. 2018. PMID: 29422423 Review.
-
Anticancer Activity of Artemisinin and its Derivatives.Anticancer Res. 2017 Nov;37(11):5995-6003. doi: 10.21873/anticanres.12046. Anticancer Res. 2017. PMID: 29061778 Review.
Cited by
-
Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells.Daru. 2024 Jun;32(1):133-144. doi: 10.1007/s40199-023-00495-7. Epub 2024 Jan 3. Daru. 2024. PMID: 38168007
-
Computational biology and in vitro studies for anticipating cancer-related molecular targets of sweet wormwood (Artemisia annua).BMC Complement Med Ther. 2023 Sep 8;23(1):312. doi: 10.1186/s12906-023-04135-0. BMC Complement Med Ther. 2023. PMID: 37684586 Free PMC article.
-
Anti-Cancer Effects of Artesunate in Human 3D Tumor Models of Different Complexity.Int J Mol Sci. 2023 Apr 25;24(9):7844. doi: 10.3390/ijms24097844. Int J Mol Sci. 2023. PMID: 37175551 Free PMC article.
-
Artemisinin derivatives induce oxidative stress leading to DNA damage and caspase-mediated apoptosis in Theileria annulata-transformed cells.Cell Commun Signal. 2023 Apr 17;21(1):78. doi: 10.1186/s12964-023-01067-7. Cell Commun Signal. 2023. PMID: 37069625 Free PMC article.
-
Zinc Protoporphyrin-9 Potentiates the Anticancer Activity of Dihydroartemisinin.Antioxidants (Basel). 2023 Jan 22;12(2):250. doi: 10.3390/antiox12020250. Antioxidants (Basel). 2023. PMID: 36829809 Free PMC article.
References
-
- Chen P.Q., Li G.Q., Guo X.B., He K.R., Fu Y.X., Fu L.C., Song Y.Z. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin. Med. J. 1994;107:709–711. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources